GSE163862 2 V 3 CISPLATIN MOUSE DN (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE163862 2 V 3 CISPLATIN MOUSE DN.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE163862 2 V 3 CISPLATIN MOUSE DN.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE163862 2 V 3 CISPLATIN MOUSE DN.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE163862 2 V 3 CISPLATIN MOUSE DN.

Results found

Linked to

 

Label

Description

 

Gene

mitochondrial rRNA methyltransferase 3

Gene

cap methyltransferase 1

Gene

cystinosin, lysosomal cystine transporter

Gene

glycine cleavage system protein H

Gene

lecithin retinol acyltransferase

Gene

TP53RK binding protein

Gene

CCR4-NOT transcription complex subunit 6 like

Gene

transmembrane p24 trafficking protein 7

Gene

estrogen receptor binding site associated antigen 9

Gene

glutaredoxin 2

  • Gene

    mitochondrial rRNA methyltransferase 3


  • Gene

    cap methyltransferase 1


  • Gene

    cystinosin, lysosomal cystine transporter


  • Gene

    glycine cleavage system protein H


  • Gene

    lecithin retinol acyltransferase


  • Gene

    TP53RK binding protein


  • Gene

    CCR4-NOT transcription complex subunit 6 like


  • Gene

    transmembrane p24 trafficking protein 7


  • Gene

    estrogen receptor binding site associated antigen 9


  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.